Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126925301 | 12692530 | 1 | I | 200706 | 20071022 | 20160829 | 20160829 | PER | US-ASTRAZENECA-2007BM17777 | ASTRAZENECA | 58.00 | YR | F | Y | 99.80000 | KG | 20160829 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126925301 | 12692530 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||||||
| 126925301 | 12692530 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | A297166 | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QD | ||||||
| 126925301 | 12692530 | 3 | SS | BYDUREON | EXENATIDE | 1 | Subcutaneous | 0 | 2 | MG | /wk | ||||||||
| 126925301 | 12692530 | 4 | C | EXENATIDE | EXENATIDE | 1 | 0 | SOLUTION FOR INJECTION | |||||||||||
| 126925301 | 12692530 | 5 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | UNK UNK, QD | 0 | QD | |||||||||
| 126925301 | 12692530 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, QD | 0 | 1000 | MG | QD | |||||||
| 126925301 | 12692530 | 7 | C | INSULIN | INSULIN NOS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126925301 | 12692530 | 1 | Type 2 diabetes mellitus |
| 126925301 | 12692530 | 2 | Type 2 diabetes mellitus |
| 126925301 | 12692530 | 3 | Type 2 diabetes mellitus |
| 126925301 | 12692530 | 5 | Type 2 diabetes mellitus |
| 126925301 | 12692530 | 6 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126925301 | 12692530 | Blood glucose decreased | |
| 126925301 | 12692530 | Blood glucose increased | |
| 126925301 | 12692530 | Confusional state | |
| 126925301 | 12692530 | Diarrhoea | |
| 126925301 | 12692530 | Intentional device misuse | |
| 126925301 | 12692530 | Off label use | |
| 126925301 | 12692530 | Product quality issue | |
| 126925301 | 12692530 | Underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126925301 | 12692530 | 1 | 200705 | 200706 | 0 | |
| 126925301 | 12692530 | 2 | 200706 | 0 | ||
| 126925301 | 12692530 | 3 | 201605 | 0 | ||
| 126925301 | 12692530 | 5 | 200705 | 0 | ||
| 126925301 | 12692530 | 6 | 2000 | 0 | ||
| 126925301 | 12692530 | 7 | 201605 | 0 |